118 related articles for article (PubMed ID: 976311)
21. Human bone marrow lymphocytes. Cytotoxic effector cells in the bone marrow of normal individuals.
Fauci AS; Balow JE; Pratt KR
J Clin Invest; 1976 Apr; 57(4):826-35. PubMed ID: 947955
[TBL] [Abstract][Full Text] [Related]
22. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. II. Identification as a K cell.
Melewicz FM; Shore SL; Ades EW; Phillips DJ
J Immunol; 1977 Feb; 118(2):567-73. PubMed ID: 65428
[TBL] [Abstract][Full Text] [Related]
23. Ala-1: murine alloantigen of activated lymphocytes. II. T and B effector cells express ala-1.
Feeney AJ; Hämmerling U
J Immunol; 1977 Apr; 118(4):1488-94. PubMed ID: 66297
[TBL] [Abstract][Full Text] [Related]
24. Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells.
West WH; Cannon GB; Kay HD; Bonnard GD; Herberman RB
J Immunol; 1977 Jan; 118(1):355-61. PubMed ID: 299761
[TBL] [Abstract][Full Text] [Related]
25. Reticulum cell sarcoma: an effector cell in antibody-dependent cell-mediated immunity.
Ralph P; Prichard J; Cohn M
J Immunol; 1975 Feb; 114(2 pt 2):898-905. PubMed ID: 1089721
[TBL] [Abstract][Full Text] [Related]
26. Studies on the cytotoxic activity of human lymphocytes. II. Interactions between IgG and Fc receptors leading to inhibition of K cell function.
Ziegler HK; Henney CS
J Immunol; 1977 Sep; 119(3):1010-7. PubMed ID: 894025
[TBL] [Abstract][Full Text] [Related]
27. Separation of effector cells mediating antibody-dependent cellular cytotoxicity (ADC) to erythrocyte targets from those mediating ADC to tumor targets.
Pollack SB; Nelson K; Grausz JD
J Immunol; 1976 Apr; 116(4):944-6. PubMed ID: 815438
[TBL] [Abstract][Full Text] [Related]
28. Ontogeny of the antibody-forming cell line in mice. IV. Appearance of cells bearing Fc receptors, complement receptors, and surface immunoglobulin.
Rosenberg YJ; Parish CR
J Immunol; 1977 Feb; 118(2):612-7. PubMed ID: 320262
[TBL] [Abstract][Full Text] [Related]
29. Fc receptors on mouse effector cells mediating natural cytotoxicity against tumor cells.
Herberman RB; Bartram S; Haskill JS; Nunn M; Holden HT; West WH
J Immunol; 1977 Jul; 119(1):322-6. PubMed ID: 326962
[TBL] [Abstract][Full Text] [Related]
30. The effect of cytochalasin B on effector--target cell interaction. Quantitative and ultrastructural study.
Kalina M; Hollander N
Immunology; 1975 Oct; 29(4):709-17. PubMed ID: 1184117
[TBL] [Abstract][Full Text] [Related]
31. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. I. Identification of the population of effector cells.
Shore SL; Melewicz FM; Gordon DS
J Immunol; 1977 Feb; 118(2):558-66. PubMed ID: 190316
[TBL] [Abstract][Full Text] [Related]
32. Characterization of cytolytic effector cells in peripheral blood of healthy individuals and cancer patients. I. Surface markers and K cell activity after separation of B cells and lymphocytes and Fc-receptors by column fractionation.
Pape GR; Troye M; Perlmann P
J Immunol; 1977 Jun; 118(6):1919-24. PubMed ID: 325129
[No Abstract] [Full Text] [Related]
33. Distinctive functional properties of human blood L lymphocytes: a comparison with T lymphocytes, B lymphocytes, and monocytes.
Horwitz DA; Garrett MA
J Immunol; 1977 May; 118(5):1712-21. PubMed ID: 140193
[TBL] [Abstract][Full Text] [Related]
34. Human natural killer-like activity against mouse spleen cells.
Yamamoto JK; Blalock JE; Johnson HM
Eur J Immunol; 1982 Mar; 12(3):222-7. PubMed ID: 7047174
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. III. Ultrastructural studies.
Penfold PL; Greenberg AH; Roitt IM
Clin Exp Immunol; 1976 Jan; 23(1):91-7. PubMed ID: 1261093
[TBL] [Abstract][Full Text] [Related]
36. Effect of tumor cells on the generation of cytotoxic T lymphocytes in vitro. I. Accessory cell functions of mouse tumor cells in the generation of cytotoxic T lymphocytes in vitro: replacement of adherent phagocytic cells by tumor cells or 2-mercaptoethanol.
Koren HS; Hodes RJ
Eur J Immunol; 1977 Jun; 7(6):394-400. PubMed ID: 302208
[TBL] [Abstract][Full Text] [Related]
37. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.
Vierling JM; Nelson DL; Strober W; Bundy DM; Jones EA
J Clin Invest; 1977 Nov; 60(5):1116-28. PubMed ID: 332716
[TBL] [Abstract][Full Text] [Related]
38. Cell-mediated cytotoxicity in vitro: target-cell recognition and effector-cell requirements.
Perlmann P; Holm G; Stejskal V
Transplant Proc; 1973 Dec; 5(4):1625-9. PubMed ID: 4272822
[No Abstract] [Full Text] [Related]
39. BCG-induced murine effector cells. II. Characterization of natural killer cells in peritoneal exudates.
Wolfe SA; Tracey DE; Henney CS
J Immunol; 1977 Sep; 119(3):1152-8. PubMed ID: 330750
[TBL] [Abstract][Full Text] [Related]
40. Antibody-dependent cell-mediated cytotoxicity in humans. I. Characterization of the effector cell.
Trinchieri G; Bauman P; De Marchi M; Tökés Z
J Immunol; 1975 Jul; 115(1):249-55. PubMed ID: 125298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
